XML 28 R14.htm IDEA: XBRL DOCUMENT v3.24.3
Equity-Based Compensation
9 Months Ended
Sep. 30, 2024
Equity-Based Compensation  
Equity-Based Compensation

8. Equity-Based Compensation

The Company recorded equity-based compensation expense related to all equity-based awards, which was allocated as follows in the consolidated statements of operations and comprehensive loss for the three and nine months ended September 30, 2024 and 2023 (in thousands):

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

    

2024

    

2023

    

2024

    

2023

Research and development expense

$

4,398

$

2,858

$

11,980

$

8,341

General and administrative expense

 

5,252

 

4,345

 

15,146

 

11,850

$

9,650

$

7,203

$

27,126

$

20,191

The following table summarizes the Company’s unrecognized equity-based compensation expense as of September 30, 2024:

As of September 30, 2024

Unrecognized Expense (in thousands)

    

Weighted Average Remaining Period of Recognition (years)

Restricted Stock Units

$

35,001

2.8

Stock Options

40,456

2.6

$

75,457

Restricted Stock Units

The following table summarizes the Company’s restricted stock unit activity for the current year:

Weighted

Average Grant

    

Number of Units

    

Date Fair Value

Restricted stock units as of December 31, 2023

 

2,089,552

$

11.92

Granted

 

2,126,820

$

13.52

Vested

 

(649,559)

$

12.38

Forfeited

 

(179,956)

$

12.42

Restricted stock units as of September 30, 2024

 

3,386,857

$

12.82

The total fair value of restricted stock units vested during the nine months ended September 30, 2024 was $8.6 million.

Stock Options

The following table summarizes the Company’s stock option activity for the current year:

Weighted

Weighted

Average

Number of 

Average

Remaining

Aggregate

    

Shares

    

Exercise Price

    

Contractual Term

    

Intrinsic Value

(in years)

(in thousands)

Outstanding as of December 31, 2023

 

7,300,953

$

15.00

7.90

$

52,299

Granted

 

2,835,756

$

13.52

Exercised

(94,988)

$

5.79

Cancelled

 

(371,557)

$

19.94

Outstanding as of September 30, 2024

 

9,670,164

$

14.47

7.80

$

2,967

Options exercisable as of September 30, 2024

 

4,831,989

$

16.50

6.72

$

2,310

Using the Black-Scholes option pricing model, the weighted average fair value of options granted during the nine months ended September 30, 2024 was $10.38.

The following weighted average assumptions were used in determining the fair value of options granted in the nine months ended September 30, 2024 and 2023:

Nine Months Ended

September 30, 

2024

    

2023

Risk-free interest rate

4.09

%  

3.87

%

Expected dividend yield

0.0

%  

0.0

%

Expected term (years to liquidity)

6.00

6.12

Expected volatility

91.15

%  

90.54

%